BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 8464494)

  • 1. Neurotoxicity of a prion protein fragment.
    Forloni G; Angeretti N; Chiesa R; Monzani E; Salmona M; Bugiani O; Tagliavini F
    Nature; 1993 Apr; 362(6420):543-6. PubMed ID: 8464494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment.
    Brown DR; Schmidt B; Kretzschmar HA
    Nature; 1996 Mar; 380(6572):345-7. PubMed ID: 8598929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro.
    Tagliavini F; Forloni G; Colombo L; Rossi G; Girola L; Canciani B; Angeretti N; Giampaolo L; Peressini E; Awan T; De Gioia L; Ragg E; Bugiani O; Salmona M
    J Mol Biol; 2000 Jul; 300(5):1309-22. PubMed ID: 10903871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion.
    Pillot T; Lins L; Goethals M; Vanloo B; Baert J; Vandekerckhove J; Rosseneu M; Brasseur R
    J Mol Biol; 1997 Dec; 274(3):381-93. PubMed ID: 9405147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligodendrocytes are susceptible to apoptotic cell death induced by prion protein-derived peptides.
    Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Olivier JL; Pillot T
    Glia; 2004 Jul; 47(1):1-8. PubMed ID: 15139007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A neurotoxic and gliotrophic fragment of the prion protein increases plasma membrane microviscosity.
    Salmona M; Forloni G; Diomede L; Algeri M; De Gioia L; Angeretti N; Giaccone G; Tagliavini F; Bugiani O
    Neurobiol Dis; 1997; 4(1):47-57. PubMed ID: 9258911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural localization of cellular prion protein (PrPc) in synaptic boutons of normal hamster hippocampus.
    Fournier JG; Escaig-Haye F; Billette de Villemeur T; Robain O
    C R Acad Sci III; 1995 Mar; 318(3):339-44. PubMed ID: 7788502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BSE: can we predict the future?
    Plum J
    Bull Mem Acad R Med Belg; 1997; 152(6):264-73. PubMed ID: 9581370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PrP27-30 is a normal soluble prion protein fragment released by human platelets.
    Perini F; Vidal R; Ghetti B; Tagliavini F; Frangione B; Prelli F
    Biochem Biophys Res Commun; 1996 Jun; 223(3):572-7. PubMed ID: 8687437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
    Cronier S; Laude H; Peyrin JM
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A process of programmed cell death as a mechanisms of neuronal death in prion diseases].
    Chrétien F; Dorandeu A; Adle-Biassette H; Ereau T; Wingertsmann L; Brion F; Gray F
    Clin Exp Pathol; 1999; 47(3-4):181-91. PubMed ID: 10472738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humanin rescues cortical neurons from prion-peptide-induced apoptosis.
    Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Pillot T
    Mol Cell Neurosci; 2004 Jan; 25(1):95-102. PubMed ID: 14962743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells.
    Dupiereux I; Zorzi W; Rachidi W; Zorzi D; Pierard O; Lhereux B; Heinen E; Elmoualij B
    J Neurosci Res; 2006 Aug; 84(3):637-46. PubMed ID: 16786576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
    Liemann S; Glockshuber R
    Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
    Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S
    Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
    Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
    J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmissible spongiform encephalopathies.
    Liemann S; Glockshuber R
    Biochem Biophys Res Commun; 1998 Sep; 250(2):187-93. PubMed ID: 9753605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo toxicity of prion protein in murine scrapie: ultrastructural and immunogold studies.
    Jeffrey M; Goodsir CM; Bruce ME; McBride PA; Fraser JR
    Neuropathol Appl Neurobiol; 1997 Apr; 23(2):93-101. PubMed ID: 9160894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.
    White AR; Guirguis R; Brazier MW; Jobling MF; Hill AF; Beyreuther K; Barrow CJ; Masters CL; Collins SJ; Cappai R
    Neurobiol Dis; 2001 Apr; 8(2):299-316. PubMed ID: 11300725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.